Billy Evans, accomplice of Theranos founder Elizabeth Holmes, is engaged on a brand new startup that seeks to ship “human well being optimization” by means of blood testing, in keeping with The New York Occasions.
The Occasions reportedly spoke to 2 traders pitched on the startup, referred to as Haemanthus, and likewise seen a few of Haemanthus’ advertising supplies.
In these supplies, the corporate says it has developed a machine that makes use of lasers to research blood, saliva, and urine samples to detect most cancers and infections. It reportedly plans to start out with pet well being earlier than increasing to people, and it seeks to boost greater than $50 million.
The pitch echoes that for Theranos, which promised to conduct quite a lot of medical assessments on tiny quantities of blood drawn from pricked fingers. In 2022, Holmes (with whom Evans has two kids) was sentenced to 11 years in jail for defrauding traders, although she mentioned in a latest interview that she stays “utterly dedicated to my dream of constructing reasonably priced healthcare options out there to everybody.”
Early Fb investor Jim Breyer informed The Occasions that his group was requested to take a position however declined “for most of the identical causes we handed twice on Theranos.”
